DETECTION AND TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

Authors

  • O. O. Yakimenko Odesa National Medical University
  • Ie. O. Maznichenko Odesa National Medical University

DOI:

https://doi.org/10.11603/2415-8798.2018.3.9412

Keywords:

familial hypercholesterolemia, hypolipidemic therapy, statins

Abstract

At present, the problem of the detection and treatment of patients with atherosclerosis is mainly due to the fact that there is no nationwide program to combat atherosclerosis, cholesterol screening and other risk factors, there is not enough adequate awareness of the population on the issues of this specialty and media support, ineffective vascular centers concerning reduction of lethality, insufficient patient adherence to the treatment, failure to reach the target levels of low density lipoprotein and inherent fear of administration the maximal doses of statins. Over the last decade, many data have been accumulated on familial hypercholesterolemia, and it is known that the prevalence of the disease has been more frequent than previously anticipated. Familial hypercholesterolemia is a hereditary disease that is associated with the early development of aggressive atherosclerosis and cardiovascular disease at young age, and is characterized by a severe course with high mortality. The paper provides an overview of the current state of epidemiology, prevention and management of patients with familial hypercholesterolemia, emphasizes the early detection of patients and screening of the family.

Published

2018-10-12

How to Cite

Yakimenko, O. O., & Maznichenko, I. O. (2018). DETECTION AND TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA. Bulletin of Scientific Research, (3), 146–151. https://doi.org/10.11603/2415-8798.2018.3.9412

Issue

Section

EXCHANGE OF EXPERIENCE